InceptionR’s CareDx CDNA Stock Holding History

InceptionR’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,807	Closed	-$204K	–	674
2025 Q4	$204K	Buy	+10,807	New	+$181K	0.06%	542
2025 Q1	–	Sell	-11,229	Closed	-$240K	–	579
2024 Q4	$240K	Buy	+11,229	New	+$273K	0.05%	524
2024 Q3	–	Sell	-13,311	Closed	-$207K	–	660
2024 Q2	$207K	Buy	+13,311	New	+$161K	0.06%	509

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

InceptionR's CDNA Position: Q1 2026 in Review

InceptionR sold out of CareDx (CDNA) in Q1 2026, closing a stake of 10,807 shares — an estimated $204K sold.

InceptionR first reported a position in CDNA in Q2 2024 and held it in 3 quarters. The position peaked at $240K in Q4 2024. 191 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

InceptionR reported no remaining CareDx position as of Q1 2026 after selling out during the quarter.
InceptionR sold 10,807 CareDx shares in Q1 2026, an estimated $204K.
InceptionR first reported a position in CareDx in Q2 2024 and held it in 3 quarters.
InceptionR's CareDx position peaked at $240K in Q4 2024.
191 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on InceptionR's 13F filing for Q1 2026, filed 14 May 2026.